HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 258 filers reported holding HAEMONETICS CORP in Q4 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $983,947 | +5.8% | 10,984 | +0.6% | 0.03% | +9.7% |
| Q2 2023 | $929,986 | +1.5% | 10,923 | -1.3% | 0.03% | -3.1% |
| Q1 2023 | $915,964 | -29.7% | 11,069 | -33.2% | 0.03% | -31.9% |
| Q4 2022 | $1,303,234 | +7.5% | 16,570 | +1.2% | 0.05% | +4.4% |
| Q3 2022 | $1,212,000 | +15.6% | 16,374 | +1.9% | 0.04% | +15.4% |
| Q2 2022 | $1,048,000 | +3.6% | 16,072 | +0.4% | 0.04% | +21.9% |
| Q1 2022 | $1,012,000 | +17.0% | 16,007 | -1.8% | 0.03% | +23.1% |
| Q4 2021 | $865,000 | -24.8% | 16,300 | 0.0% | 0.03% | -29.7% |
| Q3 2021 | $1,151,000 | +54.5% | 16,300 | +96.2% | 0.04% | -19.6% |
| Q2 2018 | $745,000 | +22.5% | 8,308 | -0.1% | 0.05% | +17.9% |
| Q1 2018 | $608,000 | -46.5% | 8,316 | -57.5% | 0.04% | -47.3% |
| Q4 2017 | $1,136,000 | +29.8% | 19,558 | +0.3% | 0.07% | +23.3% |
| Q3 2017 | $875,000 | +17.3% | 19,498 | +3.2% | 0.06% | +11.1% |
| Q2 2017 | $746,000 | +5.5% | 18,892 | +8.4% | 0.05% | 0.0% |
| Q1 2017 | $707,000 | +13.1% | 17,429 | +12.1% | 0.05% | +5.9% |
| Q4 2016 | $625,000 | +9.6% | 15,546 | -1.3% | 0.05% | +4.1% |
| Q3 2016 | $570,000 | +26.4% | 15,755 | +1.3% | 0.05% | +22.5% |
| Q2 2016 | $451,000 | -19.8% | 15,558 | -3.2% | 0.04% | -21.6% |
| Q1 2016 | $562,000 | +18.8% | 16,072 | +9.5% | 0.05% | +18.6% |
| Q4 2015 | $473,000 | +23.5% | 14,675 | +23.8% | 0.04% | +19.4% |
| Q3 2015 | $383,000 | -22.2% | 11,853 | -0.3% | 0.04% | -20.0% |
| Q2 2015 | $492,000 | -8.4% | 11,894 | -0.6% | 0.04% | -11.8% |
| Q1 2015 | $537,000 | +35.6% | 11,964 | +13.1% | 0.05% | +27.5% |
| Q4 2014 | $396,000 | -2.0% | 10,576 | -8.5% | 0.04% | -4.8% |
| Q3 2014 | $404,000 | -16.2% | 11,560 | -15.3% | 0.04% | -14.3% |
| Q2 2014 | $482,000 | +8.3% | 13,654 | +0.0% | 0.05% | +2.1% |
| Q1 2014 | $445,000 | -23.9% | 13,648 | -1.8% | 0.05% | -26.2% |
| Q4 2013 | $585,000 | – | 13,896 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
| Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
| HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
| Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
| Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
| Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
| ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
| CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
| Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |